Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control

Parasites and Vectors

Volumn 4, Issue 1, 2011, Pages

  Njenga, Sammy M ^a   Mwandawiro, Charles S ^a   Wamae, C Njeri ^a,b   Mukoko, Dunstan A ^c   Omar, Anisa A ^c   Shimada, Masaaki ^a,d   Bockarie, Moses J ^e   Molyneux, David H ^e  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b KENYA METHODIST UNIVERSITY   (Kenya)

^c Ministry of Public Health and Sanitation   (Kenya)

^d NAGASAKI UNIVERSITY   (Japan)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; ANTIFILARIAL AGENT;

ADOLESCENT; ADULT; ARTICLE; BED NET; CHILD; DISEASE TRANSMISSION; HUMAN; LYMPHATIC FILARIASIS; MALARIA; MALARIA CONTROL; MASS DRUG ADMINISTRATION; MASS IMMUNIZATION; MOSQUITO; MULTICENTER STUDY; OUTCOME ASSESSMENT; SCHOOL CHILD; VECTOR CONTROL; WUCHERERIA BANCROFTI; AGED; CHEMOPROPHYLAXIS; FEMALE; KENYA; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; PROTECTIVE EQUIPMENT; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; ELEPHANTIASIS, FILARIAL; FEMALE; FILARICIDES; HUMANS; INSECTICIDE-TREATED BEDNETS; KENYA; LONGITUDINAL STUDIES; MALARIA; MALE; MIDDLE AGED; PREVALENCE; PROTECTIVE DEVICES; YOUNG ADULT;

EID: 80052031327     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-4-90     Document Type: Article

References (35)

1. Elimination of lymphatic filariasis as a public health problem. World Health Organization, WHA50/1997/REC/1 Geneva 1997
2. Global Programme to Eliminate Lymphatic Filariasis. World Health Organization, Weekly Epidemiological Record 2006 81 22 221 232 16749186
3. Global programme to eliminate lymphatic filariasis: Progress report on mass drug administration in 2007. World Health Organization, Weekly Epidemiological Record 2008 83 37 333 348 18788146
4. Global programme to eliminate lymphatic filariasis: Progress report on mass drug administration in 2008. World Health Organization, Weekly Epidemiological Record 2009 84 437 444 19860021
5. Strategies and tools for the control/elimination of lymphatic filariasis. EA Ottesen BO Duke M Karam K Behbehani, Bull World Health Organ 1997 75 6 491 503 9509621 (Pubitemid 28099975)
6. Mosquito vectors of bancroftian filariasis in Kwale District, Kenya. CS Mwandawiro Y Fujimaki Y Mitsui M Katsivo, East Afr Med J 1997 74 5 288 293 9337005
7. Impact of insecticide-treated materials on filaria transmission by the various species of vector mosquito in Africa. EM Pedersen DA Mukoko, Ann Trop Med Parasitol 2002 96 Suppl 2 91 95 12625922
8. Studies on the transmission and prevalence of Bancroftian filariasis in four coastal villages of Tanzania. JE McMahon SA Magayauka N Kolstrup FW Mosha FM Bushrod DE Abaru JH Bryan, Ann Trop Med Parasitol 1981 75 4 415 431 6118103 (Pubitemid 11021781)
9. Bancroftian filariasis in Kenya I. Prevalence survey among adult males in the Coast Province. DJ Wijers, Ann Trop Med Parasitol 1977 71 3 313 331 335990 (Pubitemid 8201186)
10. Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis. World Health Organization, WHO/CDSA/CPE/CEE/2000.15 Geneva 2000
11. Immuno-parasitological assessment of bancroftian filariasis in a highly endemic area along the River Sabaki, in Malindi district, Kenya. SM Njenga CN Wamae CS Mwandawiro DH Molyneux, Ann Trop Med Parasitol 2007 101 2 161 172 10.1179/136485907X156933 17316502 (Pubitemid 47488164)
12. Chronic clinical manifestations related to Wuchereria bancrofti infection in a highly endemic area in Kenya. SM Njenga CN Wamae DW Njomo CS Mwandawiro DH Molyneux, Trans R Soc Trop Med Hyg 2007 101 5 439 444 10.1016/j.trstmh.2006.09. 006 17145069 (Pubitemid 46381488)
13. Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya. SM Njenga CN Wamae DW Njomo CS Mwandawiro DH Molyneux, Trans R Soc Trop Med Hyg 2008 102 10 1017 1024 10.1016/j.trstmh.2008.04.039 18550135
14. Bancroftian filariasis: a comparison of microfilariae counting techniques using counting chamber, standard slide and membrane (nuclepore) filtration. JE McMahon TF Marshall JP Vaughan DE Abaru, Ann Trop Med Parasitol 1979 73 5 457 464 393190 (Pubitemid 10243569)
15. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. JP Vandenbroucke E von Elm DG Altman PC Gotzsche CD Mulrow SJ Pocock C Poole JJ Schlesselman M Egger, Ann Intern Med 2007 147 8 163 194 17938389
16. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. GJ Weil W Kastens M Susapu SJ Laney SA Williams CL King JW Kazura MJ Bockarie, PLoS Negl Trop Dis 2008 2 12 344 10.1371/journal.pntd.0000344 19065257
17. LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages. WA Stolk SJ de Vlas GJ Borsboom JD Habbema, Parasitology 2008 135 13 1583 1598 10.1017/ S0031182008000437 19006602
18. A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti. A Boyd KY Won SK McClintock CV Donovan SJ Laney SA Williams N Pilotte TG Streit MV Beau de Rochars PJ Lammie, PLoS Negl Trop Dis 2010 4 3 640 10.1371/journal.pntd.0000640 20351776
19. Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. D Kyelem G Biswas MJ Bockarie MH Bradley M El-Setouhy PU Fischer RH Henderson JW Kazura PJ Lammie SM Njenga EA Ottesen KD Ramaiah FO Richards GJ Weil SA Williams, Am J Trop Med Hyg 2008 79 4 480 484 18840733
20. Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. S Chanteau JP Moulia-Pelat P Glaziou NL Nguyen P Luquiaud C Plichart PM Martin JL Cartel, J Infect Dis 1994 170 1 247 250 10.1093/infdis/170.1.247 8014511 (Pubitemid 24186457)
21. Circulating parasite antigen in Brugia pahangi-infected jirds. GJ Weil R Chandrashekar F Liftis CS McVay SC Bosshardt TR Klei, J Parasitol 1990 76 1 78 84 10.2307/3282631 2405144 (Pubitemid 20112064)
22. Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. PJ Lammie G Weil R Noordin P Kaliraj C Steel D Goodman VB Lakshmikanthan E Ottesen, Filaria J 2004 3 1 9 10.1186/1475-2883-3-9 15347425
23. Lymphatic filariasis: Treatment, control and elimination. EA Ottesen, Adv Parasitol 2006 61 395 441 16735170 (Pubitemid 43777024)
24. Application of a polymerase chain reaction-ELISA to detect Wuchereria bancrofti in pools of wild-caught Anopheles punctulatus in a filariasis control area in Papua New Guinea. MJ Bockarie P Fischer SA Williams PA Zimmerman L Griffin MP Alpers JW Kazura, Am J Trop Med Hyg 2000 62 3 363 367 11037778
25. PCR and mosquito dissection as tools to monitor filarial infection levels following mass treatment. DS Goodman JN Orelus JM Roberts PJ Lammie TG Streit, Filaria J 2003 2 1 11 10.1186/1475-2883-2-11 12890288
26. Recent advances in molecular diagnostic techniques for human lymphatic filariasis and their use in epidemiological research. RM Ramzy, Trans R Soc Trop Med Hyg 2002 96 Suppl 1 225 229 12055843
27. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. RM Ramzy M El Setouhy H Helmy ES Ahmed KM Abd Elaziz HA Farid WD Shannon GJ Weil, Lancet 2006 367 9515 992 999 10.1016/S0140-6736(06)68426-2 16564361
28. Assessing the impact of a missed mass drug administration in Haiti. KY Won M Beau de Rochars D Kyelem TG Streit PJ Lammie, PLoS Negl Trop Dis 2009 3 8 443 10.1371/journal.pntd.0000443 19707279
29. Role of vector control in the global program to eliminate lymphatic filariasis. MJ Bockarie EM Pedersen GB White E Michael, Annu Rev Entomol 2009 54 469 487 10.1146/annurev.ento.54.110807.090626 18798707
30. Evidence to support the inclusion of vector control strategies in the global effort to eliminate lymphatic filariasis. E Thomsen L Reimer A Kapa H Dogoro M Baea DJ Tisch PA Zimmerman P Siba JW Kazura, Am J Trop Med Hyg 2010 83 318
31. Epidemiology of Wuchereria bancrofti in Leogane, Haiti. CP Raccurt RC Lowrie Jr SP Katz YT Duverseau, Trans R Soc Trop Med Hyg 1988 82 5 721 725 10.1016/0035-9203(88)90214-3 3075358
32. Increasing coverage and decreasing inequity in insecticide-treated bed net use among rural Kenyan children. AM Noor AA Amin WS Akhwale RW Snow, PLoS Med 2007 4 8 255 10.1371/journal.pmed.0040255 17713981
33. The decline in paediatric malaria admissions on the coast of Kenya. EA Okiro SI Hay PW Gikandi SK Sharif AM Noor N Peshu K Marsh RW Snow, Malar J 2007 6 151 10.1186/1475-2875-6-151 18005422
34. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. WP O'Meara P Bejon TW Mwangi EA Okiro N Peshu RW Snow CR Newton K Marsh, Lancet 2008 372 9649 1555 1562 10.1016/S0140-6736(08)61655-4 18984188
35. Vector control of filariasis in the Solomon Islands. RH Webber, Southeast Asian J Trop Med Public Health 1975 6 3 430 434 3855